Supplementary Tables.docx (27.43 kB)

Supplementary Tables – Efficacy of adjuvant EGFR inhibitors and impact of clinical factors in resected EGFR-mutated NSCLC：A meta-analysis

dataset

posted on 2022-02-03, 09:38 authored by Figshare Future Science GroupFigshare Future Science Group, Likun Chen, Meichen Li, Xue Hou, Suxia Lin, Lie Zheng, Jianzhong Liang, Jing Chen, Na Wang, Baishen Zhang

Supplementary Table 1. Efficacy of adjuvant EGFR inhibitors and impact of clinical factors in resected EGFR-mutated NSCLC：A meta-analysis

The data available status for subgroup-analyses among the included trials.

Supplementary Table 2. Efficacy of adjuvant EGFR inhibitors and impact of clinical factors in resected EGFR-mutated NSCLC：A meta-analysis

Sensitivity analysis after removing the trials using the third-generation EGFR TKI.

Supplementary Table 3. Efficacy of adjuvant EGFR inhibitors and impact of clinical factors in resected EGFR-mutated NSCLC：A meta-analysis

Sensitivity analysis after removing the trials unselecting EGFR mutation status.

Supplementary Table 4. Efficacy of adjuvant EGFR inhibitors and impact of clinical factors in resected EGFR-mutated NSCLC：A meta-analysis

Sensitivity analysis using both fixed-effects and random-effects models.

Funding